https://wtop.com/wp-content/uploads/2021/05/WtopNewsLogo_500x500-150×150.png
Maryland News – WTOP News
Gaithersburg, Maryland-based Novavax says it achieved 80% efficacy in adolescents aged 12 through 17 in clinical trials across the U.S.
Md.-based Novavax says COVID-19 vaccine effective in teens
